Publication of Cancellation of Entries for Kinds of Medical Devices from the Australian Register of Therapeutic Goods - Born Brands Pty Ltd - 163606

Overview

The Therapeutic Goods Amendment (2012 Measures and Other Amendments) Act 2013, enacted in 2013, was introduced to address issues and gaps in the regulation of therapeutic goods in Australia, ensuring that only safe and effective products are available to consumers. This Act was passed by the Parliament of the Commonwealth of Australia with the policy objective of enhancing the safety and quality of therapeutic goods. One of the measures introduced by this Act was the addition of section 41GP to the Therapeutic Goods Act 1989, empowering the Therapeutic Goods Administration to cancel entries for kinds of medical devices from the Australian Register of Therapeutic Goods under certain conditions. This measure ensures that non-compliant devices can be swiftly removed from the market, protecting public health. In line with this legislative framework, the Department of Health, through a delegate such as Dr. Jane Cook, can publish the cancellation of entries for kinds of medical devices from the ARTG. This was demonstrated in a specific instance where the entry for a particular kind of pillow manufactured by Born Brands Pty Ltd was cancelled due to the sponsor's failure to comply with a notice under section 41JA, which required further information about the device. The cancellation was published on 7 March 2014 and became effective on 10 March 2014, ensuring that non-compliant products are not available for sale in Australia.

Scope and Application

The Therapeutic Goods Act 1989 applies to any person or entity involved in the supply of therapeutic goods, including medical devices, within Australia. The Act encompasses a broad range of activities, including the importation, supply, and advertising of therapeutic goods. It extends to any individual or organisation that engages in these activities, whether for profit or not, ensuring that all therapeutic goods available in Australia meet safety, quality, and efficacy standards. The Act has a national jurisdictional reach, applying across the Commonwealth of Australia, including all states and territories. However, it is noteworthy that the Act does not apply to goods for personal use that are carried by an individual for that purpose, certain blood and blood components, or therapeutic goods supplied for research purposes. The scope of the Act can be extended through subordinate instruments, which provide further detail on specific aspects of therapeutic goods regulation, including the specific processes for registering, assessing, and monitoring these goods.

Key Provisions

The primary operative sections of this legislation (section 41GP of the Therapeutic Goods Act 1989) involve the cancellation of entries for kinds of medical devices from the Australian Register of Therapeutic Goods (ARTG). Specifically, this Act pertains to the cancellation of an entry for a particular type of pillow manufactured by Born Brands Pty Ltd, as identified by ARTG number 163606. This cancellation is effective from 10 March 2014 and is due to the sponsor's failure to comply with a notice under section 41JA within the specified timeframe, which required further information about the kind of medical device. The Act imposes specific obligations on parties involved with the registration and maintenance of entries in the ARTG. The sponsor of the medical device, in this case Born Brands Pty Ltd, is responsible for ensuring that all necessary information is provided to the Therapeutic Goods Administration (TGA) within the stipulated time frames. Failure to comply with these requirements can result in the cancellation of the entry, as seen with the aforementioned pillow. It is crucial for sponsors to maintain accurate and up-to-date records and to respond promptly to any requests for additional information from the TGA. In terms of consequences for non-compliance, the Act does not explicitly detail offences or penalties for the failure to provide required information or for the cancellation of entries. However, the cancellation of an ARTG entry can have significant implications for the sponsor, including the inability to legally market the medical device in Australia. While the specific penalties for such breaches are not outlined in this particular notification, general provisions within the Therapeutic Goods Act may apply. These could include fines, legal action, or other administrative penalties imposed by the TGA. Sponsors are therefore encouraged to adhere strictly to all regulatory requirements to avoid any potential negative outcomes.